Regeneron Pharmaceuticals
REGN
#295
Rank
โ‚น7.265 T
Marketcap
โ‚น68,546
Share price
1.31%
Change (1 day)
19.27%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚น446.36 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.24 Billion. In 2024 the company made an earning of โ‚น436.18 Billion, an increase over its 2023 earnings that were of โ‚น383.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น446.36 B2.33%
2024 โ‚น436.18 B13.83%
2023 โ‚น383.20 B-13.57%
2022 โ‚น443.38 B-47.9%
2021 โ‚น851.02 B144.75%
2020 โ‚น347.71 B56.86%
2019 โ‚น221.66 B-4.87%
2018 โ‚น233.02 B22.86%
2017 โ‚น189.67 B56.3%
2016 โ‚น121.35 B8.55%
2015 โ‚น111.79 B54.53%
2014 โ‚น72.34 B11.14%
2013 โ‚น65.09 B72.13%
2012 โ‚น37.81 B-285.93%
2011 -โ‚น20.35 Billion121.73%
2010 -โ‚น9.18 Billion37.18%
2009 -โ‚น6.69 Billion-14.6%
2008 -โ‚น7.84 Billion-25.02%
2007 -โ‚น10.45 Billion6.32%
2006 -โ‚น9.83 Billion-186.52%
2005 โ‚น11.35 B2103.7%
2004 โ‚น0.51 B-105.66%
2003 -โ‚น9.11 Billion-18.18%
2002 -โ‚น11.13 Billion42.33%
2001 -โ‚น7.82 Billion129.35%
2000 -โ‚น3.41 Billion51.87%
1999 -โ‚น2.25 Billion92.19%
1998 -โ‚น1.17 Billion66.23%
1997 -โ‚น0.71 Billion-55.49%
1996 -โ‚น1.58 Billion103.53%
1995 -โ‚น0.78 Billion-70.89%
1994 -โ‚น2.67 Billion-26.08%
1993 -โ‚น3.61 Billion114.67%
1992 -โ‚น1.68 Billion196.77%
1991 -โ‚น0.57 Billion87.88%
1990 -โ‚น0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.956 T 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.498 T 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น752.30 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น830.44 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น173.74 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.89 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA